Nonetheless, as the analyzed cohort contained very few cases of distant metastasis, more patients’ data is yet to be collected to further assess the contribution of ACTBL2 to enhanced cellular motility in the course of ovarian cancer development with special regard to metastatic mechanisms. This evidence concerns the gene ACTBL2 and ovarian cancer.